GGrantIndex
Sort

40,608 grants matching prostate cancer

Behavioral Science Education - Cancer Prevention and Control

$524,819
Patricia Dolan Mullen · University Of Texas Hlth Sci Ctr Houston · R25 · FY2009 · CA

Analyses of human T regulatory cells

$524,784
Kwong Yok Tsang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Identification of human tumor-associated antigens

$524,784
Kwong Yok Tsang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy

$524,728
Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Pathogenesis of human prostate carcinomas

$524,673
University Of Southern California · R01 · FY2003 · CA

Dissecting neomorphic functions mediated by mutant-specific structures of SPOP

$524,560
Tanja Mittag · St. Jude Children'S Research Hospital · R01 · FY2025 · CA

Shared Resources Core-1: Integrated Clinical, Tissue, and Biomarker Data Base Core (ICTBD Core)

$524,556
Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2018 · CA

Developing Selective EphA2 Inhibitors for the treatment of Cancer

$524,549
Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2013 · CA

Developing Selective EphA2 Inhibitors for the treatment of Cancer

$524,549
Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Pax2 Interacting Proteins in Development and Disease

$524,535
Gregory R Dressler · University Of Michigan At Ann Arbor · R01 · FY2016 · DK

Behavioral Economics Applications to Geriatrics Leveraging EHRs (BEAGLE)

$524,502
Stephen Persell · Northwestern University At Chicago · R33 · FY2021 · AG

Predicting Prostate Cancer Aggressiveness

$524,496
Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2013 · CA

ROLE OF DOPAMINE AS AN ANTIANGIOGENIC AGENT IN THE TREATMENT OF PROSTATE CANCER

$524,460
Ohio State University Research Foundation, The · · FY2008 · Department of Defense

Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression

$524,453
Kenneth J. Pienta · Johns Hopkins University · U01 · FY2013 · CA

Circulating Tumor Cell Capture & Analysis in a Multi-Center Prostate Cancer Trial

$524,400
Richard James Cote · University Of Miami School Of Medicine · R01 · FY2009 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$524,358
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Vaccine and radiation for the therapy of human cancers

$524,358
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Bladder Cancer Program

$524,287
Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Neovascular-Direct Nanoparticles for Detection, Characterization, and Treatment

$524,194
Gregory M Lanza · Washington University · U54 · FY2009 · CA

Prostate Cancer Risk Enhancers

$524,114
Peggy J Farnham · University Of Southern California · R01 · FY2019 · CA

Study the role(s) of p53 in embryonic stem cells

$524,002
Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate Cancer

$523,982
Akash Patnaik · University Of Chicago · R01 · FY2023 · CA

Behavioral Science Education - Cancer Prevention and Control

$523,890
Patricia Dolan Mullen · University Of Texas Hlth Sci Ctr Houston · R25 · FY2010 · CA

Development of FISH Molecular Diagnostics to support Clinical Trials at NCI

$523,886
Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2012 · CA

Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality

$523,852
Heather Cheng · Fred Hutchinson Cancer Center · P50 · FY2023 · CA